Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases

Detalles Bibliográficos
Autores principales: Zalpoor, Hamidreza, Akbari, Abdullatif, Nabi-Afjadi, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977187/
https://www.ncbi.nlm.nih.gov/pubmed/35377105
http://dx.doi.org/10.1007/s13577-022-00697-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977187/
https://www.ncbi.nlm.nih.gov/pubmed/35377105
http://dx.doi.org/10.1007/s13577-022-00697-2

Ejemplares similares